Help Therapeutics

Help Therapeutics is a stem cell biotechnology company dedicated to developing regenerative medicine for intractable diseases. The company harnesses the therapeutic potential of stem cells to develop new medicine targeting neurological, cardiovascular, and immunological diseases. HELP has engineered a stem cell differentiation platform mimicking native developmental niches to generate high-quality cell products and established a genome editing platform fostering the addition of novel functions to cell products. Founded in 2016 by Founder & CEO Dr. Eugene Wang, the company received a $25.00M Series C investment on 15 November 2021 from Share Capital, Purple Bull Startups, 浩悦资本, Golden Rain Bogor, Bison Capital (China), Ming Bioventures, Jolmo Capital, and other ventures. HELP aims to restore health by delivering next-generation medicine to patients in need and to be a top employer for R&D talents. The company offers a variety of R&D-oriented positions and encourages candidates with a passion for shaping tomorrow’s medicine to explore career opportunities by contacting them via LinkedIn or the company website. The company is headquartered in China and operates in the Biotechnology and Healthcare industries.